Feedback's Bleepa chosen by CVS equine division

The AIM-traded firm said that, following a successful pilot trial, CVS had adopted Bleepa for initial use in the division, with the platform to be rolled-out across 20 equine specialist surgeries.

It said the current agreement would result in increased Bleepa users, and provide scope for a broader relationship with CVS.

Additionally, the Feedback board said the deal highlighted the scalability of Bleepa, and the company's ability to target non-NHS markets by tailoring the platform.

As part of the pilot, Feedback worked with CVS to adapt Bleepa, providing the features needed for veterinary service, both within the surgery and in the field.

Feedback said that previously, vets were not able to easily acquire x-rays in a field and share them with colleagues.

Bleepa developed an image push capability that enabled x-rays to be “securely pushed” from the x-ray machine over a cellular network to the Bleepa platform.

The platform then made these images available to specialists for immediate review and discussion, allowing the correct treatment guidance for the injured animal to be communicated to the vet and be provided at first visit.

That capability meant that images could now be taken “in any location”, and could be “instantly shared” with specialist colleagues for timely advice and guidance.

Feedback said the technology had “clear applications” in both military and rural care delivery in developing countries.

“CVS is an important partner for Feedback and we are delighted to now be working with them officially,” said chief executive officer Tom Oakley.

“Their validation of our technology and expertise demonstrates the flexibility of Bleepa within new markets.

“By purchasing Bleepa, CVS have evidenced a real commitment to empower their vets by connecting them with specialist colleagues at the point of care, ultimately resulting in excellent animal care at the touch of a button, anywhere in the world.”

At 1351 BST, shares in Bleepa were up 2.42% at 0.85p.